Bgm (BGM) Construction in Progress (2019 - 2025)
Bgm (BGM) posted quarterly Construction in Progress of $4.0 million for Q3 2025, down 28.52% year-over-year from $5.6 million in Q3 2024, and up 4.0% quarter-over-quarter from $3.9 million in Q1 2025.
Bgm (BGM) Construction in Progress (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Construction in Progress for 7 consecutive years, with $4.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Construction in Progress fell 28.52% year-over-year to $4.0 million; the TTM figure through Sep 2025 stood at $4.0 million (down 28.52% YoY), while the FY2025 annual figure was $4.0 million, down 28.52% from the prior year.
- Construction in Progress grew to $4.0 million in Q3 2025 per BGM's latest filing, from $3.9 million in the prior quarter.
- Across five years, Construction in Progress topped out at $5.6 million in Q3 2024 and bottomed at $1.2 million in Q3 2022.
- Historically, Construction in Progress has averaged $3.3 million across 5 years, with a median of $3.6 million in 2024.
- Annual changes were most pronounced in 2021 — Construction in Progress jumped 1170.93% — and 2022, when it slumped 40.67%.
- Bgm's Construction in Progress stood at $2.0 million in 2021, then plunged by 40.67% to $1.2 million in 2022, then soared by 139.22% to $2.9 million in 2023, then soared by 96.68% to $5.6 million in 2024, then declined by 28.52% to $4.0 million in 2025.
- Business Quant data shows BGM's Construction in Progress at $4.0 million in Q3 2025, $3.9 million in Q1 2025, and $5.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.03 Mn |
| Mar 31, 2025 | 3.88 Mn |
| Sep 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 3.65 Mn |
| Sep 30, 2023 | 2.87 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Sep 30, 2021 | 2.02 Mn |
| Sep 30, 2020 | 158,975.00 |
| Sep 30, 2019 | 148,197.00 |